Hematopoietic Stem Cell TransplantationTransplantation, HomologousStem Cell TransplantationGraft vs Host DiseaseTransplantation ConditioningTransplantation, AutologousPeripheral Blood Stem Cell TransplantationHematologic NeoplasmsTransplantation ChimeraBone Marrow TransplantationStem CellsGraft vs Leukemia EffectMyeloablative AgonistsTissue DonorsBusulfanTreatment OutcomeGraft SurvivalVidarabineRemission InductionRecurrenceGraft vs Tumor EffectHistocompatibility TestingHematopoietic Stem CellsLymphocyte TransfusionCord Blood Stem Cell TransplantationImmunosuppressive AgentsWhole-Body IrradiationLeukemiaLeukemia, Myeloid, AcuteBone and BonesMultiple MyelomaRetrospective StudiesCombined Modality TherapyLeukemia, Myelogenous, Chronic, BCR-ABL PositiveSiblingsCytomegalovirus InfectionsMinor Histocompatibility AntigensLymphocyte DepletionSalvage TherapyHistocompatibilityDisease-Free SurvivalAntilymphocyte SerumSurvival AnalysisMyelodysplastic SyndromesLiver TransplantationSurvival RateVirus ActivationNeoplasm, ResidualChimerismPrecursor Cell Lymphoblastic Leukemia-LymphomaMelphalanMesenchymal Stem Cell TransplantationHematopoietic Stem Cell MobilizationTime FactorsHepatic Veno-Occlusive DiseaseAntigens, CD34CyclophosphamideBone Marrow CellsT-LymphocytesAntineoplastic Combined Chemotherapy ProtocolsCytomegalovirusBone MarrowAnemia, AplasticCell TransplantationAcute DiseasePrimary MyelofibrosisHLA AntigensHematologic DiseasesEmbryonic Stem CellsFollow-Up StudiesKidney TransplantationTransplantation ImmunologyImmunosuppressionPrognosisLeukemia, Myeloid, Accelerated PhaseAntibodies, NeoplasmAdult Stem CellsRoseolovirus InfectionsCytarabineLeukemia, MyeloidGranulocyte Colony-Stimulating FactorGraft RejectionBenzamidesImmunocompromised HostLymphoproliferative DisordersAntineoplastic AgentsFusion Proteins, bcr-ablCell DifferentiationHodgkin DiseaseNuclear FamilyReceptors, Purinergic P2X5PyrimidinesFlow CytometryLymphoma, Non-HodgkinTransplantation, IsogeneicInfectionGanciclovirCyclosporineBone RemodelingLeukocyte Transfusion